HALOZYME THERAPEUTICS, INC. Taxes Payable, Current
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2026-08-06
- 2026-06-30: Taxes Payable, Current $26.43M.
- 2026-03-31: Taxes Payable, Current $48.01M.
- 2025-12-31: Taxes Payable, Current $44.15M.
- 2025-09-30: Taxes Payable, Current $26.02M.
| Period end | Taxes Payable, Current |
|---|---|
| 2026-06-30 | $26.43M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $48.01M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $44.15M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $26.02M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $24.96M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $57.96M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $31.00M 10-Q · filed 2025-11-03 |
| 2024-09-30 | $3.52M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $29.27M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $19.07M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $963.00K 10-Q · filed 2024-10-31 |
| 2023-09-30 | $18.03M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $7.94M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.64M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-06 |
| 2022-09-30 | $9.41M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $23.04M 10-Q · filed 2022-08-09 |
| 2021-12-31 | $1.44M 10-Q · filed 2022-11-08 |